Cooke patent opposition analysis

The comprehensive analysis of Cooke opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Cooke

Patent NumberTitleApplicantOpposition DateOpposition Company
Method For Treating Primary InsomniaNEURIM PHARMACEUTICALSFeb 9, 2018GENERICS UK
Crystalline Naloxol-Peg ConjugateNEKTAR THERAPEUTICSSep 16, 2016GENERICS UK
Engineered Polypeptides Having Enhanced Duration Of ActionAMYLIN PHARMACEUTICALSSep 14, 2016GENERICS UK
Tablets For Combination TherapyGILEAD SCIENCESApr 29, 2016COOKE
Flavor Impregnation Of A Chewing Gum CoreFERTIN PHARMAJan 15, 2016GENERICS UK
Dexamethasone Combination TherapyBOARD OF REGENTSJan 8, 2016GENERICS UK
Regimens For Intra-Articular ViscosupplementationGENZYMEDec 3, 2015GENERICS UK
Therapy And Prevention Of Problem DrinkingTHE UNIVERSITY OF SYDNEYApr 2, 2015GENERICS UK TRADING MYLAN
Biodegradable Ocular Implants With Long-Term Release CharacteristicsALLERGANMar 25, 2015GENERICS UK TRADING MYLAN
Sustained Release Formulation Comprising Octreotide And Two Or More Polylactide-Co-Glycolide PolymersNOVARTISFeb 16, 2015GENERICS UK TRADING MYLAN

Top companies who are the clients of Cooke